HDAC9
Histone deacetylase 9
As of the edition of 20 October 2026, HDAC9 (histone deacetylase 9, UniProt Q9UKV0) has 8 drugs tested at it and 10 companies on the list, 5 on route A and 0 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- Q9UKV0
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- Inside the cell
- Solved structures
- 2
- Disease areas
- Cancer; Blood and lymph; Immune system; Digestive system; Skin and connective tissue; Heart and blood vessels; Hormones; Pregnancy and women's health
- Registered trials of its drugs
- 23
Drugs at this target
| Status | Count |
|---|---|
| Active | 1 |
| Went quiet | 3 |
| Stopped | 3 |
| Status not established | 1 |
| Total | 8 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Resminostat | Active | Phase 4 | none listed |
| Remetinostat | Stopped | Phase 2 | none listed |
| Zabadinostat | Stopped | Phase 2 | none listed |
| Bocodepsin | Status not established | Phase 2 | none listed |
| Tefinostat | Went quiet | Phase 2 | none listed |
| Bisthianostat | Went quiet | Phase 1 | none listed |
| MTX110 | Stopped | Phase 1 | none listed |
| OBP-801 | Went quiet | Phase 1 | none listed |
8 of 8 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route A | 5 |
| Engaged | 3 |
| Undetermined | 2 |
| Total on the list | 10 |
| Company | Route |
|---|---|
| TetraLogic Pharmaceuticals | Route A |
| Biodexa Pharmaceuticals | Route A |
| Chroma Therapeutics | Route A |
The other 7 companies at HDAC9
In the product10 companies in all; 7 are not named here, and no score is.
See the 10 companies at HDAC9, ranked, with the facts behind eachRequest access. Nothing is shown until you do.